ACRV Earnings

Quarterly EPS
$-0.59
Q3 2024
$-0.60
Q4 2024
$-0.51
Q1 2025
$-0.55
Q2 2025
$-0.47
Q3 2025
$-0.49
Q4 2025
$-0.49
Q1 2026
$-0.43
Q2 2026
Latest RevenueN/A
Latest Net Income-17964000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.430-17964000+21.8%
Q1 2026-$0.490-19042000+3.9%
Q4 2025-$0.490-18985000+18.3%
Q3 2025-$0.470-18234000+20.3%
Q2 2025-$0.550-21006000-5.8%
Q1 2025-$0.510-19680000+30.1%
Q4 2024-$0.600-22831000+30.2%
Q3 2024-$0.590-22441000+10.6%
Q2 2024-$0.520-18798000
Q1 2024-$0.730-16486000
Q4 2023-$0.860-19252000
Q3 2023-$0.660-14466000
Acrivon Therapeutics (ACRV) — Earnings